Key result
ER-stress inhibitor normalizes neurofunctional and cognitive impairment in preclinical CKD-stroke complex.
Answers are grounded in this paper and cite their sources.
In a rat model of CKD-stroke complex, ER-stress inhibition normalized neurofunctional and cognitive impairments, highlighting Sel1L modulation as a potential therapeutic target for white matter damage.
Stroke is one of the major causes of mortality and long-term disability worldwide. Chronic-kidney-disease (CKD) is a condition where patients have shown increased vulnerability to stroke with poor functional and cognitive outcomes. Impaired cerebral autoregulation in CKD patients may impose a high risk of stroke. To date, the mechanism of worsened stroke outcomes in CKD patients are limitedly understood. Alterations of endoplasmic-reticulum (ER) homoeostasis via modification of Sel1L-Hrd1 complex is one of the many cellular events that gets triggered following both CKD and stroke leading to accumulation of misfolded proteins, culminating in ER-stress. Therefore, the present study aims to explore the involvement of Sel1L mediated altered ER functions towards worsening of stroke outcome in CKD and further its crucial role towards white matter damage. CKD-stroke complex was induced in male Sprague-Dawley rats followed by middle-cerebral-artery occlusion. At 24 h and 7th day of reperfusion, animals were subjected to behavioral analysis followed by euthanasia, brain harvest and molecular studies. CKD-Stroke-complex animals showed aggravated neurofunctional and cognitive impairment which were further normalized by treatment of an ER-stress inhibitor. This indicates exacerbated stroke outcome in CKD-stroke-complex may be mediated by imbalanced ER-homeostasis due to decreased Sel1L expression leading to enhanced cellular death and neurodegeneration. Sel1L protein modulation can regulate Endoplasmic Reticulum homeostasis imbalance mediated white matter damage in rat model of CKD-Stroke complex
No takes yet. Share an insight, caveat, or question.
Datta et al. (2025) studied CKD-stroke complex. ER-stress inhibitor vs. Untreated CKD-stroke complex was evaluated on Neurofunctional and cognitive impairment. Treatment with an ER-stress inhibitor normalized aggravated neurofunctional and cognitive impairment in a rat model of CKD-stroke complex.
Synapse has enriched 10 related papers. Consider them for comparative context: